Minimally invasive surgeries are increasing now and gaining importance among the people. Minimally invasive surgeries are now preferred over the conventional invasive surgeries due to the satisfaction of the patients as these surgeries have multiple benefits such as quick recovery time, reduced post-operative pain and reduced duration of hospital stay. Hence overall reduction in the total cost of the treatment.
Minimally Invasive Surgeries are Preferred more over the Traditional Surgeries
Minimally invasive surgeries (MIS) have been reported to cause less post-operative pain when compared with normal open surgeries and hence, receive smaller dosages of pain killers. As there are no cuts or stiches involved in the surgery, the hospital stay is reduced, and patients are not required to visit the hospital, frequently. Traditional open surgeries involve long incisions that have to be made through muscle, and these muscles take significant time to heal; whereas, MIS procedures involve smaller incisions leading to quicker recovery. Moreover, the body scars involved in MIS are barely noticeable. The prime advantage that MIS has over traditional open surgeries is the higher precision, owing to video-assisted equipment involved, which generate better and magnified images of the organs or body parts that are operated, and also wider acceptance rate in old adult population, due to the relatively shorter recovery time. and benefits such as improved patient quality of life and the increasing patient acceptance and preference over traditional open surgeries and along with the increasing prevalence of chronic disorders are driving the minimally invasive surgery devices market.
Shortage of Skilled Professionals
Lack of skilled surgeons in the minimally invasive surgery, to perform the surgery and use these surgery devices efficiently, is restricting the use of minimally invasive surgery devices in the market. Although Patients who prefer MIS are increasing every day in these countries but the number of well-trained surgeons are falling short of the demand who are required to carry out the surgery. According to the American Cancer Society, in 2018 it is estimated to be 63,230 new cases of cancer of the body of the uterus (uterine body or corpus) will be diagnosed in the US and for these patients are the standard treatment for endometrial cancer is removal of the uterus or hysterectomy. As patients who are opting for these minimally invasive surgery are increasing every year and market is falling short of skilled professional surgeons is becoming a major restrain along with stringent regulatory framework and insurance plans for medical devices is restraining for the market growth.
North America to Dominate the Market Growth
Minimally invasive surgery market is segmented based on the type of device, type of technology and by application. Under the device type segment minimally invasive surgical devices is going to witness a profitable growth during the forecast period. These surgical devices are used for carrying out all the invasive surgeries and minimally invasive interventions, Hence this segment will grow along with the overall growth of the market. and the endoscopy devices is also expected to have a positive growth rate due to their extensive use by the surgeons as the guide for the movement of surgical instruments, and also for locating the surgical site.
Key Developments in the Market
- December 2017: Smith & Nephew completed the acquisition of tissue regeneration developer Rotation Medical Inc.
- March 2017: Ethicon completed the acquisition of acquisition of Torax Medical, Inc.
- August 2017: Ethicon launched ProxiSure suturing device designed to improve precision In minimally invasive surgery
Reasons to Purchase this Report
- Current and future minimally invasive surgery market outlook in the developed and emerging markets.
- Analyzing various perspectives of the market with the help of Porter’s five forces analysis.
- The segment that is expected to dominate the market.
- Regions that are expected to witness fastest growth during the forecast period.
- Identify the latest developments, market shares and strategies employed by the major market players.
- 3 months analyst support along with the Market Estimate sheet in excel.
1.1 MARKET DEFINITION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW
5.1 CURRENT MARKET SCENARIO
5.2 PORTER’S FIVE FORCES
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF CONSUMERS
5.2.3 THREATS OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 MARKET DRIVERS
6.1.1 HIGHER ACCEPTANCE RATE OF MINIMALLY INVASIVE PROCEDURES OVER TRADITIONAL PROCEDURES
6.1.2 IMPROVED PATIENT QUALITY OF LIFE AND INCREASING NUMBER OF SURGERIES AMONG THE AGING POPULATION
6.1.3 MINIMALLY INVASIVE SURGERIES HELP REDUCE HEALTHCARE COSTS AND TIME
6.1.4 INCREASING PREVALENCE OF LIFESTYLE AND CHRONIC DISORDERS
6.2 MARKET RESTRAINTS
6.2.1 SHORTAGE OF EXPERIENCED PROFESSIONALS
6.2.2 STRINGENT REGULATORY FRAMEWORK AND INSURANCE PLANS FOR MEDICAL DEVICES
6.4 KEY CHALLENGES
7. Market Segmentation
7.1 BY PRODUCTS
7.1.1 SURGICAL EQUIPMENT
220.127.116.11 GUIDE WIRES
18.104.22.168 METAL SHAFTS
7.1.2 MONITORING & VISUALIZATION EQUIPMENT
22.214.171.124 MRI SCANNERS
126.96.36.199 CT SCANNERS
188.8.131.52 X-RAY EQUIPMENT
184.108.40.206 ULTRASOUND EQUIPMENT
7.1.3 ROBOTIC ASSISTED SURGICAL SYSTEMS
220.127.116.11 DA VINCI SYSTEMS
18.104.22.168 ZEUS ROBOTIC SURGICAL SYSTEMS
7.1.4 ELECTROSURGICAL SYSTEMS
22.214.171.124 BIPOLAR FORCEPS
126.96.36.199 ELECTROSURGICAL ACCESSORIES
188.8.131.52 SUCTION COAGULATORS
184.108.40.206 LAPAROSCOPIC INSTRUMENTS
7.2 BY TECHNOLOGY
7.2.3 ROBOT - ASSISTED METHODS
7.2.4 ARTHROSCOPIC TECHNIQUES
7.2.5 ABLATIVE TECHNIQUES
7.3 BY APLLICATION
7.3.1 CARDIAC SURGERY
7.3.2 COLORECTAL SURGERY
7.3.3 DERMATOLOGICAL SURGERY
7.3.4 ENT SURGERY
7.3.5 GASTROINTESTINAL SURGERY
7.3.6 GYNECOLOGIC SURGERY
7.3.7 LUNG & RESPIRATORY CARE
7.3.12 WEIGHT LOSS
8. COMPETITIVE LANDSCAPE
8.1 MERGERS AND ACQUISITIONS
8.2 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS
8.3 NEW PRODUCT LAUNCHES
9. KEY PLAYERS
9.1 GE HEALTHCARE
9.2 PHILIPS HEALTHCARE
9.3 SIEMENS HEALTHCARE
9.4 MEDTRONIC INC.
9.5 STRYKER CORPORATION
9.6 ZIMMER BIOMET
9.7 DEPUY SYNTHES INC.
9.8 INTUITIVE SURGICAL INC.
9.9 ETHICON INC.
9.10 SMITH & NEPHEW PLC
10. FUTURE OUTLOOK OF THE MARKET